APO RESEARCH · REPORT
Veterinary Insulin Syringes
Veterinary insulin syringes provide concentration-specific graduations and a small-volume delivery configuration for insulin products used in veterinary applications.
Product & engineering
Understand the product.
Veterinary labelling does not make different unit scales interchangeable. The specified concentration, graduations and needle configuration remain separate requirements.
What turns activity into demand
Device demand is defined by container or delivery function, connection, materials and validated manufacturing. Prefilling adds formulation compatibility and storage integrity to the device boundary.
The commercial boundary
Injection, enteral, oral and analytical devices have different interfaces and intended uses. Representative images establish neither sterility nor clinical suitability.
Which concentration does the graduation scale assume?
Veterinary labelling does not make different unit scales interchangeable. The specified concentration, graduations and needle configuration remain separate requirements.
Selected research
Industry Research
Veterinary Insulin Syringes Industry Research Report 2026
Market perspective
The global Veterinary Insulin Syringes market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Veterinary Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Veterinary Insulin Syringes is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Veterinary Insulin Syringes is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Veterinary Insulin Syringes include B. Braun VetCare, BD, Cardinal Health, CarePoint VET, Covetrus, Knight Benedikt, MWI Veterinary Supply, Pharma Supply and SOL-Millennium, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Veterinary Insulin Syringes market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Insulin Syringes Market by Company
B. Braun VetCare
BD
Cardinal Health
CarePoint VET
Covetrus
Knight Benedikt
MWI Veterinary Supply
Pharma Supply
SOL-Millennium
Trividia Health
UltiMed
Medtronic
Merck
Veterinary Insulin Syringes Segment by Type
U-40
U-100
Veterinary Insulin Syringes Segment by Application
Companion Animals
Livestock Animals
Veterinary Insulin Syringes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Insulin Syringes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Insulin Syringes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Insulin Syringes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Insulin Syringes manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Insulin Syringes by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Insulin Syringes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- U-40
- U-100
Applications
- Companion Animals
- Livestock Animals
Companies covered
- B. Braun VetCare
- BD
- Cardinal Health
- CarePoint VET
- Covetrus
- Knight Benedikt
- MWI Veterinary Supply
- Pharma Supply
- SOL-Millennium
- Trividia Health
- UltiMed
- Medtronic
- Merck
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Veterinary Insulin Syringes Market Size (2021-2032)
- 2.2.2 Global Veterinary Insulin Syringes Sales (2021-2032)
- 2.2.3 Global Veterinary Insulin Syringes Market Average Price (2021-2032)
- 2.3 Veterinary Insulin Syringes by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 U-40
- 2.3.3 U-100
- 2.4 Veterinary Insulin Syringes by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Companion Animals
- 2.4.3 Livestock Animals
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Veterinary Insulin Syringes Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Veterinary Insulin Syringes Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Veterinary Insulin Syringes Revenue of Manufacturers (2021-2026)
- 3.4 Global Veterinary Insulin Syringes Average Price by Manufacturers (2021-2026)
- 3.5 Global Veterinary Insulin Syringes Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Veterinary Insulin Syringes, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Veterinary Insulin Syringes, Product Type & Application
- 3.8 Global Manufacturers of Veterinary Insulin Syringes, Established Date
- 3.9 Global Veterinary Insulin Syringes Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 B. Braun VetCare
- 4.1.1 B. Braun VetCare Company Information
- 4.1.2 B. Braun VetCare Business Overview
- 4.1.3 B. Braun VetCare Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 B. Braun VetCare Veterinary Insulin Syringes Product Portfolio
- 4.1.5 B. Braun VetCare Recent Developments
- 4.2 BD
- 4.2.1 BD Company Information
- 4.2.2 BD Business Overview
- 4.2.3 BD Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 BD Veterinary Insulin Syringes Product Portfolio
- 4.2.5 BD Recent Developments
- 4.3 Cardinal Health
- 4.3.1 Cardinal Health Company Information
- 4.3.2 Cardinal Health Business Overview
- 4.3.3 Cardinal Health Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cardinal Health Veterinary Insulin Syringes Product Portfolio
- 4.3.5 Cardinal Health Recent Developments
- 4.4 CarePoint VET
- 4.4.1 CarePoint VET Company Information
- 4.4.2 CarePoint VET Business Overview
- 4.4.3 CarePoint VET Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 CarePoint VET Veterinary Insulin Syringes Product Portfolio
- 4.4.5 CarePoint VET Recent Developments
- 4.5 Covetrus
- 4.5.1 Covetrus Company Information
- 4.5.2 Covetrus Business Overview
- 4.5.3 Covetrus Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Covetrus Veterinary Insulin Syringes Product Portfolio
- 4.5.5 Covetrus Recent Developments
- 4.6 Knight Benedikt
- 4.6.1 Knight Benedikt Company Information
- 4.6.2 Knight Benedikt Business Overview
- 4.6.3 Knight Benedikt Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Knight Benedikt Veterinary Insulin Syringes Product Portfolio
- 4.6.5 Knight Benedikt Recent Developments
- 4.7 MWI Veterinary Supply
- 4.7.1 MWI Veterinary Supply Company Information
- 4.7.2 MWI Veterinary Supply Business Overview
- 4.7.3 MWI Veterinary Supply Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 MWI Veterinary Supply Veterinary Insulin Syringes Product Portfolio
- 4.7.5 MWI Veterinary Supply Recent Developments
- 4.8 Pharma Supply
- 4.8.1 Pharma Supply Company Information
- 4.8.2 Pharma Supply Business Overview
- 4.8.3 Pharma Supply Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pharma Supply Veterinary Insulin Syringes Product Portfolio
- 4.8.5 Pharma Supply Recent Developments
- 4.9 SOL-Millennium
- 4.9.1 SOL-Millennium Company Information
- 4.9.2 SOL-Millennium Business Overview
- 4.9.3 SOL-Millennium Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 SOL-Millennium Veterinary Insulin Syringes Product Portfolio
- 4.9.5 SOL-Millennium Recent Developments
- 4.10 Trividia Health
- 4.10.1 Trividia Health Company Information
- 4.10.2 Trividia Health Business Overview
- 4.10.3 Trividia Health Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Trividia Health Veterinary Insulin Syringes Product Portfolio
- 4.10.5 Trividia Health Recent Developments
- 4.11 UltiMed
- 4.11.1 UltiMed Company Information
- 4.11.2 UltiMed Business Overview
- 4.11.3 UltiMed Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 UltiMed Veterinary Insulin Syringes Product Portfolio
- 4.11.5 UltiMed Recent Developments
- 4.12 Medtronic
- 4.12.1 Medtronic Company Information
- 4.12.2 Medtronic Business Overview
- 4.12.3 Medtronic Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Medtronic Veterinary Insulin Syringes Product Portfolio
- 4.12.5 Medtronic Recent Developments
- 4.13 Merck
- 4.13.1 Merck Company Information
- 4.13.2 Merck Business Overview
- 4.13.3 Merck Veterinary Insulin Syringes Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Merck Veterinary Insulin Syringes Product Portfolio
- 4.13.5 Merck Recent Developments
5 Global Veterinary Insulin Syringes Market Scenario by Region
- 5.1 Global Veterinary Insulin Syringes Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Veterinary Insulin Syringes Sales by Region: 2021-2032
- 5.2.1 Global Veterinary Insulin Syringes Sales by Region: 2021-2026
- 5.2.2 Global Veterinary Insulin Syringes Sales by Region: 2027-2032
- 5.3 Global Veterinary Insulin Syringes Revenue by Region: 2021-2032
- 5.3.1 Global Veterinary Insulin Syringes Revenue by Region: 2021-2026
- 5.3.2 Global Veterinary Insulin Syringes Revenue by Region: 2027-2032
- 5.4 North America Veterinary Insulin Syringes Market Facts & Figures by Country
- 5.4.1 North America Veterinary Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Veterinary Insulin Syringes Sales by Country (2021-2032)
- 5.4.3 North America Veterinary Insulin Syringes Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Veterinary Insulin Syringes Market Facts & Figures by Country
- 5.5.1 Europe Veterinary Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Veterinary Insulin Syringes Sales by Country (2021-2032)
- 5.5.3 Europe Veterinary Insulin Syringes Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Veterinary Insulin Syringes Market Facts & Figures by Country
- 5.6.1 Asia Pacific Veterinary Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Veterinary Insulin Syringes Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Veterinary Insulin Syringes Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Veterinary Insulin Syringes Market Facts & Figures by Country
- 5.7.1 South America Veterinary Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Veterinary Insulin Syringes Sales by Country (2021-2032)
- 5.7.3 South America Veterinary Insulin Syringes Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Veterinary Insulin Syringes Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Veterinary Insulin Syringes Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Veterinary Insulin Syringes Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Veterinary Insulin Syringes Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Veterinary Insulin Syringes Sales by Type (2021-2032)
- 6.1.1 Global Veterinary Insulin Syringes Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Veterinary Insulin Syringes Sales Market Share by Type (2021-2032)
- 6.2 Global Veterinary Insulin Syringes Revenue by Type (2021-2032)
- 6.2.1 Global Veterinary Insulin Syringes Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Veterinary Insulin Syringes Revenue Market Share by Type (2021-2032)
- 6.3 Global Veterinary Insulin Syringes Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Veterinary Insulin Syringes Sales by Application (2021-2032)
- 7.1.1 Global Veterinary Insulin Syringes Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Veterinary Insulin Syringes Sales Market Share by Application (2021-2032)
- 7.2 Global Veterinary Insulin Syringes Revenue by Application (2021-2032)
- 7.2.1 Global Veterinary Insulin Syringes Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Veterinary Insulin Syringes Revenue Market Share by Application (2021-2032)
- 7.3 Global Veterinary Insulin Syringes Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Veterinary Insulin Syringes Value Chain Analysis
- 8.1.1 Veterinary Insulin Syringes Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Veterinary Insulin Syringes Production Mode & Process
- 8.2 Veterinary Insulin Syringes Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Veterinary Insulin Syringes Distributors
- 8.2.3 Veterinary Insulin Syringes Customers
9 Global Veterinary Insulin Syringes Analyzing Market Dynamics
- 9.1 Veterinary Insulin Syringes Industry Trends
- 9.2 Veterinary Insulin Syringes Industry Drivers
- 9.3 Veterinary Insulin Syringes Industry Opportunities and Challenges
- 9.4 Veterinary Insulin Syringes Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst